538 related articles for article (PubMed ID: 21965443)
1. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
[TBL] [Abstract][Full Text] [Related]
2. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
Lee JM; Choi KH; Lim BW; Kim MW; Kim J
J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA
Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
Terzis JK; Karypidis D
J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
[TBL] [Abstract][Full Text] [Related]
6. Platysma synkinesis in facial palsy and botulinum toxin type A.
Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies in post-facial paralysis synkinesis in adult patients.
Terzis JK; Karypidis D
Plast Reconstr Surg; 2012 Jun; 129(6):925e-939e. PubMed ID: 22634691
[TBL] [Abstract][Full Text] [Related]
8. Long-term facial improvement after repeated BoNT-A injections and mirror biofeedback exercises for chronic facial synkinesis: a case-series study.
Mandrini S; Comelli M; Dall'angelo A; Togni R; Cecini M; Pavese C; Dalla Toffola E
Eur J Phys Rehabil Med; 2016 Dec; 52(6):810-818. PubMed ID: 27164539
[TBL] [Abstract][Full Text] [Related]
9. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation.
Ito H; Ito H; Nakano S; Kusaka H
Acta Neurol Scand; 2007 Apr; 115(4):271-4. PubMed ID: 17376126
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Mirror Biofeedback Rehabilitation on Synkinesis in Acute Stage Facial Palsy in Children.
Baba S; Kondo K; Yoshitomi A; Kanemaru A; Nakaya M; Yamasoba T
Otol Neurotol; 2021 Aug; 42(7):e936-e941. PubMed ID: 33741820
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
Hjelm N; Crippen M; Azizzadeh B
Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
[No Abstract] [Full Text] [Related]
13. Management of synkinesis.
Husseman J; Mehta RP
Facial Plast Surg; 2008 May; 24(2):242-9. PubMed ID: 18470836
[TBL] [Abstract][Full Text] [Related]
14. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
Wei LA; Diels J; Lucarelli MJ
Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
[TBL] [Abstract][Full Text] [Related]
15. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
[TBL] [Abstract][Full Text] [Related]
17. Electroneurography in the acute stage of facial palsy as a predictive factor for the development of facial synkinesis sequela.
Azuma T; Nakamura K; Takahashi M; Miyoshi H; Toda N; Iwasaki H; Takeda N
Auris Nasus Larynx; 2018 Aug; 45(4):728-731. PubMed ID: 28966005
[TBL] [Abstract][Full Text] [Related]
18. An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire.
Neville C; Venables V; Aslet M; Nduka C; Kannan R
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1624-1628. PubMed ID: 28688864
[TBL] [Abstract][Full Text] [Related]
19. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A.
Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED
Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606
[TBL] [Abstract][Full Text] [Related]
20. Complications of botulinum toxin application: differences between hemifacial spasm and post-facial palsy synkinesis.
Cakmak MA; Sahin S; Cinar N; Karsidag S
Acta Neurol Belg; 2014 Dec; 114(4):331. PubMed ID: 24647748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
